Table 2 Descriptive statistics of study sample
From: The cost of unresectable stage III or stage IV melanoma in Italy
Italy population (N = 215) | ||
|---|---|---|
Age at diagnosis (years) | Mean | SD |
55 | 13,9 | |
Sex | N | % |
Male | 135 | 62,9% |
Female | 80 | 37,1% |
Total receiving active systemic therapy | N | % |
Overall | 208 | 96,7% |
First-line | 147 | 68,4% |
Second-line | 112 | 52,1% |
Third-line | 41 | 19,1% |
of which: | ||
any response to systematic therapy | N | % |
Overall | 89 | 42,8% |
First-line | 53 | 36,1% |
Second-line | 34 | 30,4% |
Third-line | 14 | 34,1% |
Total follow-up time (months) | Mean | SD |
Overall | 17,5 | 13 |
First-line | 9,9 | 10,7 |
Second-line | 8,9 | 7,7 |
Third-line | 7,7 | 6,7 |
Supportive care | 4,9 | 5 |
Received supportive care | N | % |
Total | 24 | 11,2% |
with at least one line of active systematic therapy | 17 | 7,9% |